US › Healthcare

Jaguar Animal Health Inc (JAGX)

US · Healthcare · Biotechnology

$3.52-23.20%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$1.2M

Revenue YoY

-58.9%

Net profit

$-12.7M

EPS

$-15.70

EPS estimate

$-52.15

Net margin

-1,035.3%

EPS came in at -15.70 against a street estimate of -52.15 — a beat of 69.9%.

Key statistics

Market cap

$8.1M

Forward P/E

200.0

P/B

0.70

Book value

$20.43

EPS (TTM)

$-4,012.65

52-week high

$1,207.50

52-week low

$2.35

50-day MA

$9.28

200-day MA

$153.28

Beta

-0.10

Analyst view

with an average price target of $262.50.

Shareholding

Insiders

4.38%

Institutions

1.77%

Largest institutional holders

Fund	Stake
UBS Group AG	0.05%
Tower Research Capital LLC	0.01%
SBI Securities Co Ltd	0.00%
Barclays PLC	0.00%
Royal Bank of Canada	0.00%
Wells Fargo & Co	0.00%
LEONTEQ SECURITIES AG	0.00%
International Assets Investment Management, LLC	0.00%

Corporate actions

Action	Detail	Date
Split	1 : 15 effective Sep 17, 2026	2026-09-17

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Jaguar Animal Health Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.